Loading...
Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy
Barohn, Richard J. Allen, Jeffery Avila, David Barboi, Alexandru Biliciler, Suur Abrams, Charles Brannigan, Thomas, III Cartwright, Michael Chahin, Nizar Chawla, Jasvinder
Barohn, Richard J.
Allen, Jeffery
Avila, David
Barboi, Alexandru
Biliciler, Suur
Abrams, Charles
Brannigan, Thomas, III
Cartwright, Michael
Chahin, Nizar
Chawla, Jasvinder
Citations
Altmetric:
Genre
Journal article
Date
2022-06-22
Advisor
Committee member
Group
Department
Neurology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.17161/rrnmf.v3i2.18133
Abstract
Description
Citation
Barohn, R. J., Abrams , C. K., Allen , J. A., Ashraf, K., Avila, J. D., Barboi, A., Bartlett, G., Bensman, J., Biliciler , S., Brannagan III, T. H., Brown, A., Callaghan, B., Cartwright , M. S., Cassone, D., Chahin, N., Chawla, J., Christie, M., Chuquilin, M. ., Collins, M. P., … Waitman, L. R. (2022). Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy. RRNMF Neuromuscular Journal, 3(2), 45-98. https://doi.org/10.17161/rrnmf.v3i2.18133
Citation to related work
The University of Kansas
Has part
RRNMF Neuromuscular Journal, Vol. 3, No. 2
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu